There’s something to be happy about today.
Nigerian PhD student of the department of chemistry at the University of Ilorin has developed a drug that promises a new light for tuberculosis.
Mistura Arowona has developed a drug that promises to be potent in the treatment of tuberculosis.
Tuberculosis is an infectious disease that attacks the lungs.
Supervised by Prof. Joshua Obaleye, former Dean, Faculty of Science of Unilorin. He also attached metal to the drug.
The drug will also improve the efficiency of anti-TB drugs compared to normal drugs that are consumed globally.
Nigeria is among the 14 high burden countries for TB, TB/HIV and multi-drug resistant TB.
“Nigeria is ranked seventh among the 30 high TB burden countries and second in Africa and the problem of TB in Nigeria has been made worse by the issues of drug-resistant TB and the HIV/AIDS”
About 407, 000 people in Nigeria have TB in a year. The Nigerian scientist used metal like ions, cobalt, copper and zinc to prepare the metallodrugs. He developed the drug with ciprofloxacin HCl, ofloxacin, pyrazinamide and moxifloxacin HCl. Presently, there is no metal-based anti-TB drug available in the market.
This is really a ground-breaking development for Nigeria and Nigerian students.
What do you think about this story?
Let us know by using the comment box below
Stay connected, subscribe below: